480 related articles for article (PubMed ID: 30012158)
1. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
Stoolman JS; Duncker PC; Huber AK; Giles DA; Washnock-Schmid JM; Soulika AM; Segal BM
J Neuroinflammation; 2018 Jul; 15(1):208. PubMed ID: 30012158
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Lee E; Chanamara S; Pleasure D; Soulika AM
J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
[TBL] [Abstract][Full Text] [Related]
3. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Bozoyan L; Dumas A; Patenaude A; Vallières L
J Neuroinflammation; 2015 Sep; 12():173. PubMed ID: 26377915
[TBL] [Abstract][Full Text] [Related]
5. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
7. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Valentin-Torres A; Savarin C; Hinton DR; Phares TW; Bergmann CC; Stohlman SA
J Neuroinflammation; 2016 Feb; 13():46. PubMed ID: 26906225
[TBL] [Abstract][Full Text] [Related]
8. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-related factors as biomarkers in EAE and MS.
Rumble JM; Huber AK; Krishnamoorthy G; Srinivasan A; Giles DA; Zhang X; Wang L; Segal BM
J Exp Med; 2015 Jan; 212(1):23-35. PubMed ID: 25559893
[TBL] [Abstract][Full Text] [Related]
10. Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis.
Stoolman JS; Duncker PC; Huber AK; Segal BM
J Immunol; 2014 Jul; 193(2):564-70. PubMed ID: 24928987
[TBL] [Abstract][Full Text] [Related]
11. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
12. Preferential Recruitment of Neutrophils into the Cerebellum and Brainstem Contributes to the Atypical Experimental Autoimmune Encephalomyelitis Phenotype.
Liu Y; Holdbrooks AT; Meares GP; Buckley JA; Benveniste EN; Qin H
J Immunol; 2015 Aug; 195(3):841-52. PubMed ID: 26085687
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
[TBL] [Abstract][Full Text] [Related]
14. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
15. CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis.
Roy M; Richard JF; Dumas A; Vallières L
J Neuroinflammation; 2012 Jan; 9():18. PubMed ID: 22269426
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
17. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
18. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.
Huang DR; Wang J; Kivisakk P; Rollins BJ; Ransohoff RM
J Exp Med; 2001 Mar; 193(6):713-26. PubMed ID: 11257138
[TBL] [Abstract][Full Text] [Related]
19. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease.
Graham KL; Zabel BA; Loghavi S; Zuniga LA; Ho PP; Sobel RA; Butcher EC
J Immunol; 2009 Nov; 183(10):6717-23. PubMed ID: 19864606
[TBL] [Abstract][Full Text] [Related]
20. Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.
Rüther BJ; Scheld M; Dreymueller D; Clarner T; Kress E; Brandenburg LO; Swartenbroekx T; Hoornaert C; Ponsaerts P; Fallier-Becker P; Beyer C; Rohr SO; Schmitz C; Chrzanowski U; Hochstrasser T; Nyamoya S; Kipp M
Glia; 2017 Dec; 65(12):1900-1913. PubMed ID: 28836302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
